Aug 4, 2026 07:39AM
Jul 23, 2026 05:00PM
Jul 22, 2026 06:52AM
Jun 25, 2026 06:41AM
Jun 22, 2026 07:30AM
May 27, 2026 07:31AM
May 20, 2026 04:30PM Palvella presents positive data for QTORIN rapamycin at vascular congress
May 13, 2026 07:30AM
May 12, 2026 02:54AM
May 7, 2026 08:10AM
May 4, 2026 08:16AM
Apr 1, 2026 10:04AM
Mar 31, 2026 04:41PM
Mar 31, 2026 03:06PM Stifel stays Buy on Palvella: multiple 'pipeline-in-a-product' opportunities
Mar 31, 2026 02:39PM
Mar 30, 2026 07:31AM
Mar 27, 2026 10:30AM
Mar 24, 2026 10:53AM
Mar 16, 2026 01:19PM
Mar 16, 2026 07:31AM
Mar 10, 2026 12:23PM Clear Street Reiterates Buy Rating on Palvella Therapeutics (PVLA) following BEYOND mLM disease-awareness campaign launch
Mar 10, 2026 07:31AM
Feb 24, 2026 02:30PM
Feb 24, 2026 01:56PM
Feb 24, 2026 01:56PM
Feb 24, 2026 01:50PM
Feb 24, 2026 11:50AM
Feb 24, 2026 10:13AM Palvella Therapeutics (PVLA) PT Raised to $255 at H.C. Wainwright
Feb 23, 2026 06:57AM
Feb 4, 2026 04:12PM
Feb 2, 2026 07:30AM
Feb 2, 2026 05:20AM
Jan 9, 2026 07:30AM
Jan 8, 2026 09:20AM
Jan 7, 2026 05:49AM Mizuho Starts Palvella Therapeutics (PVLA) at Outperform, PT $205, trading $91 handle now
Jan 2, 2026 07:32AM
Dec 16, 2025 06:54AM
Dec 16, 2025 06:09AM
Dec 16, 2025 03:50AM
Dec 15, 2025 03:03PM
Dec 15, 2025 02:14PM
Dec 15, 2025 01:49PM Clear Street on Palvella Therapeutics (PVLA): 'Management highlighted continued momentum across the pipeline'
Dec 15, 2025 12:44PM
Dec 15, 2025 12:29PM
Dec 15, 2025 12:17PM
Dec 15, 2025 10:30AM
Dec 15, 2025 10:09AM
Dec 15, 2025 10:06AM
Dec 15, 2025 08:55AM Raymond James Reiterates Strong Buy Rating on Palvella Therapeutics (PVLA)
Dec 11, 2025 06:44AM

433,993 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All